Technical refolding of proteins: Do we have freedom to operate?
The DOI matches its Crossref record.
Abstract
Expression as inclusion bodies in Escherichia coli is a widely used method for the large‐scale production of therapeutic proteins that do not require post‐translational modifications. High expression yields and simple recovery steps of inclusion bodies from the host cells are attractive features industrially. However, the value of an inclusion body‐based process is dominated by the solubilization and refolding technologies. Scale‐invariant technologies that are economical and applicable for a wide range of proteins are requested by industry. The main challenge is to convert the denatured protein into its native conformation at high yields. Refolding competes with misfolding and aggregation. Thus, the yield of native monomer depends strongly on the initial protein concentrations in the refolding solution. Reasonable yields are attained at low concentrations (≤0.1 mg/mL). However, large buffer tanks and time‐consuming concentration steps are required. We attempt to answer the question of the extent to which refolding of proteins is protected by patents. Low‐molecular mass additives have been developed to improve refolding yields through the stabilization of the protein in solution and shielding hydrophobic patches. Progress has been made in the field of high‐pressure renaturation and on‐column refolding. Mixing times of the denatured protein in the refolding buffer have been reduced using newly developed devices and the introduction of specific mixers. Concepts of continuous refolding have been introduced to reduce tank sizes and increase yields. Some of the patents covering refolding of proteins will soon expire or have already expired. This gives more freedom to operate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements
Huang, C.-J., Lin, H., & Yang, X. (2012) · Journal of Industrial Microbiology and Biotechnology · doi:10.1007/s10295-011-1082-9 · Cited by 424
Continuous downstream processing of biopharmaceuticals
Jungbauer, A. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.05.011 · Cited by 325
Self-citationRefolding Techniques for Recovering Biologically Active Recombinant Proteins from Inclusion Bodies
Yamaguchi, H., & Miyazaki, M. (2014) · Biomolecules · doi:10.3390/biom4010235 · Cited by 251
Bao, R.-M., Yang, H.-M., Yu, C.-M., Zhang, W.-F., & Tang, J.-B. (2016) · Protein Expression and Purification · doi:10.1016/j.pep.2016.05.007 · Cited by 31
Advances in monitoring and control of refolding kinetics combining PAT and modeling
Pauk, J. N., Raju Palanisamy, J., Kager, J., Koczka, K., Berghammer, G., Herwig, C., & Veiter, L. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11151-y · Cited by 25
Metadata
- Authors
- Eiberle, M. K., & Jungbauer, A.
- Venue
- Biotechnology Journal
- Publisher
- Wiley
- Published
- 2010-06
- Volume
- 5
- Issue
- 6
- Pages
- 547-559
- ISSN
- 1860-6768 (ISSN-L)
- 1860-7314
- OpenAlex
- W1973033448
- Cited by
- 108
- References
- 0
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Technical refolding of proteins: Do we have freedom to operate? https://app.cochat.ai/papers/10.1002/biot.201000001
- The paper
- Eiberle, M. K., & Jungbauer, A. (2010). Technical refolding of proteins: Do we have freedom to operate? Biotechnology Journal. https://doi.org/10.1002/biot.201000001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.